Comparison |
Country of Origin |
Unknown | Unknown | Unknown | United States | United States |
For Use With |
For VITEK 2 System | For BD Viper™ Instrument | For BD Viper™ Instrument | For use on the ACE Axcel and ACE Alera Clinical Chemistry Systems | For use on the ACE Axcel and ACE Alera Clinical Chemistry Systems |
Number of Tests |
| 1,152 Tests | 1,152 Tests | 450 Tests | 450 Tests |
Product Dating |
McKesson Acceptable Dating: we will ship >= 60 days | McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
Sample Type |
| Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Samples | Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Samples | Serum / Plasma Sample | Serum / Plasma Sample |
Storage Requirements |
| | USP Controlled Room Temperature | Requires Refrigeration | Requires Refrigeration |
Test Method |
Gram Negative Organisms | Amplified DNA Assay | | | |
Test Name |
AST-XN09 | Chlamydia Trachomatis / Neisseria Gohorrhoeae (CT / NG) | Neisseria Gonorrhoea (NG) | Alanine Aminotransferase (ALT) | Aspartate Aminotransferase (AST) |
Test Type |
Identification and Susceptibility Testing | Infectious Disease Immunoassay | DNA Amplification / Detection | Hepatic / General Chemistry | Hepatic / General Chemistry |
UNSPSC Code |
41116129 | 41116011 | 41116011 | 41116105 | 41116105 |
Volume |
| 1,152 Tests | | | R1: 3 X 12 mL, R2: 3 X 12 mL |
Application |
Reagent Kit | Reagent Kit | Reagent Kit | Reagent Kit | Reagent Kit |
Features and Benefits |
- The VITEK®2 Gram-negative Susceptibility Card is intended for use with the VITEK®2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of clinically significant aerobic Gram-negative bacilli to antimicrobial agents when used as instructed
- 20 Test Cards
- The VITEK® 2 card is the size and shape of a playing card and contains 64 microwells
- Each well contains identification substrates or antimicrobials
- The VITEK® 2 test card is sealed, which minimizes aerosols, splattering, spills, and personal contamination
- Disposable waste is reduced by more than 80% over microtiter methods
|
- Qualitative detection of Chlamydia trachomatis DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
- Qualitative detection of Neisseria gonorrhoeae DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
- For the quantitative determination of alanine aminotransferase activity in serum and lithium heparin plasma
|
- For the quantitative determination of aspartate aminotransferase activity in serum and lithium heparin plasma
|